174 related articles for article (PubMed ID: 17427533)
21. Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent.
Santamaría G; Velasco M; Farrús B; Zanón G; Fernández PL
Breast; 2008 Apr; 17(2):186-94. PubMed ID: 17964786
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of ultrasonographic images of ductal carcinoma in situ with abnormalities of the ducts.
Ban K; Tsunoda H; Watanabe T; Kaoku S; Yamaguchi T; Ueno E; Hirokaga K; Tanaka K
J Med Ultrason (2001); 2020 Jan; 47(1):107-115. PubMed ID: 31655940
[TBL] [Abstract][Full Text] [Related]
23. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging.
Menell JH; Morris EA; Dershaw DD; Abramson AF; Brogi E; Liberman L
Breast J; 2005; 11(6):382-90. PubMed ID: 16297080
[TBL] [Abstract][Full Text] [Related]
24. How significant is detection of ductal carcinoma in situ in a breast screening programme?
Kessar P; Perry N; Vinnicombe SJ; Hussain HK; Carpenter R; Wells CA
Clin Radiol; 2002 Sep; 57(9):807-14. PubMed ID: 12384106
[TBL] [Abstract][Full Text] [Related]
25. Breast scintigraphy with breast-specific γ-camera in the detection of ductal carcinoma in situ: a correlation with mammography and histologic subtype.
Spanu A; Sanna D; Chessa F; Cottu P; Manca A; Madeddu G
J Nucl Med; 2012 Oct; 53(10):1528-33. PubMed ID: 22911882
[TBL] [Abstract][Full Text] [Related]
26. Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast US in the preoperative evaluation of patients.
Moon WK; Noh DY; Im JG
Radiology; 2002 Aug; 224(2):569-76. PubMed ID: 12147858
[TBL] [Abstract][Full Text] [Related]
27. Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ.
Liberman L; Van Zee KJ; Dershaw DD; Morris EA; Abramson AF; Samli B
AJR Am J Roentgenol; 1997 Feb; 168(2):489-93. PubMed ID: 9016233
[TBL] [Abstract][Full Text] [Related]
28. Preoperative prediction of the size of pure ductal carcinoma in situ using three imaging modalities as compared to histopathological size: does magnetic resonance imaging add value?
Daniel OK; Lim SM; Kim JH; Park HS; Park S; Kim SI
Breast Cancer Res Treat; 2017 Jul; 164(2):437-444. PubMed ID: 28439735
[TBL] [Abstract][Full Text] [Related]
29. Dynamic contrast-enhanced MRI reveals the extent and the microvascular pattern of breast ductal carcinoma in situ.
Santamaría G; Velasco M; Farrús B; Caparrós FX; Fernández PL
Breast J; 2013; 19(4):402-10. PubMed ID: 23758454
[TBL] [Abstract][Full Text] [Related]
30. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
31. [MRI outstands mammogram in sensitivity of breast ductal carcinoma in situ:an analysis of 122 cases].
Yu QX; Chen XS; Wu JY; Han BS; He JR; Zhu L; Chen WG; Li YF; Tan L; Chai WM; Wang DB; Fei XC; Yuan F; Jin XL; Shen KW; Li HW
Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):26-9. PubMed ID: 23578423
[TBL] [Abstract][Full Text] [Related]
32. Clustered microcalcifications of intermediate concern detected on digital mammography: ultrasound assessment.
Yu PC; Lee YW; Chou FF; Wu SC; Huang CC; Ng SH; Sheen-Chen SM; Ko SF
Breast; 2011 Dec; 20(6):495-500. PubMed ID: 21723728
[TBL] [Abstract][Full Text] [Related]
33. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
Kuhl CK; Schrading S; Bieling HB; Wardelmann E; Leutner CC; Koenig R; Kuhn W; Schild HH
Lancet; 2007 Aug; 370(9586):485-92. PubMed ID: 17693177
[TBL] [Abstract][Full Text] [Related]
34. Non-calcified ductal carcinoma in situ: ultrasound and mammographic findings correlated with histological findings.
Cho KR; Seo BK; Kim CH; Whang KW; Kim YH; Kim BH; Woo OH; Lee YH; Chung KB
Yonsei Med J; 2008 Feb; 49(1):103-10. PubMed ID: 18306476
[TBL] [Abstract][Full Text] [Related]
35. US of ductal carcinoma in situ.
Moon WK; Myung JS; Lee YJ; Park IA; Noh DY; Im JG
Radiographics; 2002; 22(2):269-80; discussion 280-1. PubMed ID: 11896217
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
Berg WA; Gutierrez L; NessAiver MS; Carter WB; Bhargavan M; Lewis RS; Ioffe OB
Radiology; 2004 Dec; 233(3):830-49. PubMed ID: 15486214
[TBL] [Abstract][Full Text] [Related]
37. Radiographic features for triple negative ductal carcinoma in situ of the breast.
Kojima Y; Tsunoda H; Honda S; Kikuchi M; Kawauchi N; Yoshida A; Yagata H; Yamauchi H; Suzuki K
Breast Cancer; 2011 Jul; 18(3):213-20. PubMed ID: 21465228
[TBL] [Abstract][Full Text] [Related]
38. Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease?
Evans AJ; Pinder SE; Ellis IO; Wilson AR
J Med Screen; 2001; 8(3):149-51. PubMed ID: 11678555
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status.
Rauch GM; Kuerer HM; Scoggins ME; Fox PS; Benveniste AP; Park YM; Lari SA; Hobbs BP; Adrada BE; Krishnamurthy S; Yang WT
Breast Cancer Res Treat; 2013 Jun; 139(3):639-47. PubMed ID: 23774990
[TBL] [Abstract][Full Text] [Related]
40. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
Papantoniou V; Tsiouris S; Mainta E; Valotassiou V; Souvatzoglou M; Sotiropoulou M; Nakopoulou L; Lazaris D; Louvrou A; Melissinou M; Tzannetaki A; Pirmettis I; Koutsikos J; Zerva C
Breast Cancer Res; 2005; 7(1):R33-45. PubMed ID: 15642168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
